CID 10713

Dichloromethotrexate

Structural Information

Molecular Formula
C20H20Cl2N8O5
SMILES
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=C(C=C(C=C3Cl)C(=O)N[C@@H](CCC(=O)O)C(=O)O)Cl
InChI
InChI=1S/C20H20Cl2N8O5/c1-30(7-9-6-25-17-14(26-9)16(23)28-20(24)29-17)15-10(21)4-8(5-11(15)22)18(33)27-12(19(34)35)2-3-13(31)32/h4-6,12H,2-3,7H2,1H3,(H,27,33)(H,31,32)(H,34,35)(H4,23,24,25,28,29)/t12-/m0/s1
InChIKey
MCEHFIXEKNKSRW-LBPRGKRZSA-N
Compound name
(2S)-2-[[3,5-dichloro-4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

48
References

3904
Patents

522.0934 Da
Monoisotopic Mass

-0.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 523.10068 211.8
[M+Na]+ 545.08262 220.8
[M+NH4]+ 540.12722 212.8
[M+K]+ 561.05656 219.0
[M-H]- 521.08612 212.2
[M+Na-2H]- 543.06807 213.7
[M]+ 522.09285 213.0
[M]- 522.09395 213.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe